|
|
||||||||
1Department of Cardiology, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark; 2University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom; and 3Hospital for Sick Children, Toronto, Ontario, Canada
Submitted 4 March 2004 ; accepted in final form 15 October 2004
| ABSTRACT |
|---|
|
|
|---|
ischemia; transplantation; infarction; ion channels; reperfusion
| MATERIALS AND METHODS |
|---|
|
|
|---|
Male Wistar rats (M&B Taconic, 300350 g) were randomly allocated to 1 of 10 groups: 1) control (n = 10); 2) control plus glibenclamide (10 µM, n = 10); 3) control plus 5-hydroxydecanoic acid (5-HD; 100 µM, n = 10); 4) control plus HMR-1098 (100 µM, n = 10); 5) local IPC (n = 10); 6) RPC (n = 10); 7) RPC plus glibenclamide (10 µM, a nonselective KATP blocker; n = 10); 8) RPC plus 5-HD (100 µM, a mitochondrial KATP blocker; n = 10); 9) RPC plus HMR-1098 (30 µM, a sarcolemmal KATP blocker; n = 10); and 10) diazoxide (10 mg/kg, a mitochondrial KATP activator that was included in the study to confirm the role of mitochondrial KATP channels in the memory of remote IPC, n = 10). Animals were handled according to national guidelines in Denmark and the guidelines of the American Heart Association for animal research.
Preparation
Animals were anesthetized with Dormicum (Midazolam, 0.25 mg/kg body wt) and Hypnorm (Fluanisone, 0.5 mg/kg body wt) and maintained on spontaneous breathing with an oxygen supply (95% O2-5% CO2).
Diazoxide (10 mg/kg) was administrated in vivo through the femoral vein 40 min before excision of the heart.
Local IPC and RPC
RPC. A tourniquet was placed around one hindlimb to occlude blood flow for four cycles of 5-min ischemia followed by 5-min reperfusion. Circulatory arrest in the limb was confirmed by a change in the color of the skin and by a decrease in limb temperature. Limb temperature was measured at the end of 5 min of limb ischemia by a subcutaneously placed temperature probe connected to a digital thermometer. There was no difference in the temperature decrease between groups subjected to limb ischemia (RPC, 5.5 ± 0.4°C; RPC + 5-HD, 5.7 ± 0.4°C; RPC + glibenclamide, 5.6 ± 0.4°C; RPC + HMR-1098, 5.6 ± 0.4°C, P = 0.89), indicating that all groups were subjected to equal severity of limb ischemia. Furthermore, in a subset of animals, Doppler ultrasound was used to confirm total arterial occlusion to the limb. Hearts were explanted within 5 min of the final preconditioning stimulus.
Local IPC. A snare was placed around the left main coronary artery for four cycles of 2-min ischemia and 3-min reperfusion.
Induction of Myocardial Infarction
Hearts were cannulated in situ, mounted in a Langendorff preparation at a constant pressure of 80 mmHg, and perfused with a fully oxygenated Krebs-Henseleit buffer. Regional ischemia was induced by tightening a 4-0 ligature snare around the left main coronary artery. The perfusion protocol was 40 min of stabilization and 45 min of ischemia followed by 120 min of reperfusion. Glibenclamide (10 µM), 5-HD (100 µM), and HMR-1098 (30 µM, a gift from Aventis Pharma Deutchland; Frankfurt, Germany) was administered 20 min before I/R in the Langendorff preparation.
Assessment of Ventricular Function and Coronary Flow
In all animals, left ventricular (LV) pressure was monitored continuously by a fluid-filled balloon placed in the LV. Data were acquired and collected using Acqnowledge software (Biopac). Preload was adjusted to 7 mmHg. Coronary flow was measured continuously by an in-line flow probe (Transonic).
Assessment of Myocardial Infarction
While still in the Langendorff preparation, the area at risk (AAR) was defined by ligating the left anterior descending coronary artery at the site of the occlusion and infusing 2.5 ml of 1% Evans blue solution. Hearts were perfused with 3 ml of 1% 2,3,5-triphenyltetrazolium chloride (Sigma) at 37°C for 10 min at pH 7.4. The LV was cut into 2-mm slices, weighed, and photographed. The AAR, area of the LV, and infarct size (IS) were assessed by computer planimetry (Olympus Analysis software). The ratios of IS/AAR and AAR/LV were calculated. All analyses were performed blinded.
Statistics and Calculations
All values are expressed as means ± SE. LV developed pressure (LVDP) was calculated as LV systolic pressure minus LV end-diastolic pressure, and the rate-pressure product (RPP) was calculated as LVDP multiplied by heart rate. Hemodynamic comparisons during reperfusion between groups were performed by two-way ANOVA for repeated measures, whereas hemodynamic comparisons before ischemia, hindlimb temperature reduction after hindlimb ischemia, and IS/AAR were performed by one-way ANOVA. If the ANOVAs were significant, a post hoc pairwise comparison was performed using an unpaired t-test with the Bonferroni correction. P < 0.05 was considered statistical significant.
| RESULTS |
|---|
|
|
|---|
Compared with the control group, we found no significant differences in IS/AAR in the control + glibenclamide (P = 0.71), control + 5-HD (P = 0.76), and control + HMR-1098 groups (P = 0.85) (Fig. 1). IS/AAR was decreased 50% (P < 0.05) in the RPC groups and 70% (P < 0.01) in the IPC groups compared with the control group. However, the reduction of IS/AAR afforded by RPC was abolished with the addition of 5-HD and glibenclamide but not with the addition of HMR-1098. There was no significant difference in the reduction of IS/AAR between the protocols of RPC and IPC used in the present study (P = 0.81). Diazoxide also reduced IS/AAR by 50% (P < 0.05) compared with control, confirming the role mitochondrial KATP channels as an effector mechanism for memorizing RPC. We found no significant differences in the AAR expressed as a percentage of the total LV weight between IPC (0.46 ± 0.3), RPC (0.46 ± 0.4), RPC + glibenclamide (0.43 ± 0.3), RPC + 5-HD (0.45 ± 0.2), RPC + HMR-1098 (0.45 ± 0.3), diazoxide (0.47 ± 0.5), control (0.42 ± 0.2), control + glibenclamide (0.44 ± 0.3), control + HMR-1098 (0.42 ± 0.3), and control + 5-HD (0.42 ± 0.4) (P = 0.78).
|
Postischemic recovery of LVDP (Fig. 2) and RPP (Fig. 3) were superior in the RPC (LVDP: P < 0.05, RPP: P < 0.05), IPC (LVDP: P < 0.05, RPP: P < 0.05), and diazoxide groups (LVDP: P < 0.05, RPP: P < 0.05) compared with the control group. The beneficial effect of RPC on postischemic hemodynamic recovery was abolished with the addition of 5-HD and glibenclamide but not with the addition of HMR-1098. There were no differences between control + glibenclamide, control + 5-HD, and control groups in postischemic recovery of LVDP (P = 0.43) and RPP (P = 0.59) (data not shown). Coronary flow did not differ between groups (P = 0.57).
|
|
| DISCUSSION |
|---|
|
|
|---|
Inherent to the concept of IPC is the unique feature of memory, which is associated with alterations in gene expression and transcription (21) and involves KATP channels (4, 20). The concept of RPC extends memory from a temporal storage of information to a spatial storage of information because the recognition of ischemia and reperfusion in one tissue is transferred to a virginal tissue not subjected to such preceding episodes (17). Although circulating humoral factors and neuronal mechanisms are involved in the initiation and transfer of such information (3, 6), our study shows that the information is memorized within the explanted heart independently of ongoing humoral and neuronal stimulation. We used the specific KATP activator diazoxide and KATP blockers to investigate the role of KATP channels in memorization in RPC. Because Pell et al. (14) already demonstrated that activity of mitochondrial KATP channels is a prerequisite for triggering RPC (14), we focused on the effector mechanism and added KATP blockers once the heart had been explanted. Glibenclamide (a nonselective KATP blocker) and 5-HD (a selective mitochondrial KATP blocker) abolished the protection afforded by RPC to the same extent. However, HMR-1098 (a selective sarcolemmal KATP blocker) did not influence the protection afforded by RPC. HMR-1098 per se has no effect on myocardial infarct size and postischemic LV function in time-matched drug-treated controls (7, 19), although it may have some hemodynamic effects during early but not late reperfusion (18). Diazoxide administrated before excision of the heart conferred protection against I/R injury to the same extent as RPC, indicating that mitochondrial KATP channels account for the cardioprotective effect of RPC. Thus like in local IPC mitochondrial KATP channels serve both trigger and effector functions and are involved in the mechanisms for memorizing RPC (1, 5).
Our study does not allow any conclusion about the mechanism by which opening of mitochondrial KATP channels could be potentially cardioprotective. Opening of these channels decreases mitochondrial calcium overload, thus preserving mitochondrial integrity (12, 13). Mitochondrial volume is also regulated by mitochondrial KATP channels. Volume changes of the mitochondria are important because they modify energy flow through the electron system, thereby influencing efficient energy transfer between mitochondria and cellular ATPases (11). However, because opening of the channels is necessary not only during triggering but also during and after the index ischemia, mitochondrial KATP channels may also be a signal transduction element rather than an effector mechanism. Regardless of the prevailing mechanism, our data also show that the memory of RPC is critically dependent on mitochondrial KATP channels.
Although cardiac protection by RPC has been less extensively studied than local IPC, it has greater clinical applicability. The procedure described in the present study is more easily conducted than local IPC, which requires transient periods of aortic cross-clamping, and its effectiveness appears similar. Indeed, the 50% reduction in I/R we obtained with RPC obtained in studies of explanted hearts is of a magnitude that carries clinical significance and concurs with our previous in vivo studies of myocardial infarct reduction in a porcine model using a similar limb ischemia RPC protocol (10). The protection RPC affords is subsequently independent of continued neural or humoral stimulus. As such, preconditioning before profound hemodilution (e.g., cardiopulmonary bypass), in the presence of imposed regional anemia (e.g., skin flap surgery), or, for example, before heart transplantation are all potential applications of the technique.
The limitation of the present study is mainly related to the specificity of the KATP channel blockers. A former study (2) has shown that 5-HD prevented the ischemia-induced shortening of the action potential that is usually associated with the opening of sarcolemmal KATP channels. However, the concentrations of 5-HD and HMR-1098 used in the present study affect only mitochondrial and sarcolemmal KATP channels, respectively (15, 16).
In conclusion, we have shown that RPC applied in vivo exerts protection upon the heart after explantation from the body and therefore has potential beneficial effects in relation to heart transplantation, cardiopulmonary bypass, and under circumstances of predictable I/R injury of the heart. The mechanism of action is dependent on functioning mitochondrial KATP channels. The stimulus we used can easily be transferred into the clinical situation, although temporal adjustments may be required.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Shahid, M. Tauseef, K. K. Sharma, and M. Fahim Brief femoral artery ischaemia provides protection against myocardial ischaemia-reperfusion injury in rats: the possible mechanisms Exp Physiol, August 1, 2008; 93(8): 954 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hausenloy and D. M. Yellon Remote ischaemic preconditioning: underlying mechanisms and clinical application Cardiovasc Res, August 1, 2008; 79(3): 377 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chicco, M. S. Johnson, C. J. Armstrong, J. M. Lynch, R. T. Gardner, G. S. Fasen, C. P. Gillenwater, and R. L. Moore Sex-specific and exercise-acquired cardioprotection is abolished by sarcolemmal KATP channel blockade in the rat heart Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2432 - H2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Schmidt, M. Smerup, I. E. Konstantinov, M. Shimizu, J. Li, M. Cheung, P. A. White, S. B. Kristiansen, K. Sorensen, V. Dzavik, et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1883 - H1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eckle, A. Grenz, D. Kohler, A. Redel, M. Falk, B. Rolauffs, H. Osswald, F. Kehl, and H. K. Eltzschig Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2533 - H2540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Johnson, R. L. Moore, and D. A. Brown Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2644 - H2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Brown, A. J. Chicco, K. N. Jew, M. S. Johnson, J. M. Lynch, P. A. Watson, and R. L. Moore Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat J. Physiol., December 15, 2005; 569(3): 913 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Gross Remote preconditioning and delayed cardioprotection in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1562 - R1563. [Full Text] [PDF] |
||||
![]() |
I. E. Konstantinov, S. Arab, J. Li, J. G. Coles, C. Boscarino, A. Mori, E. Cukerman, F. Dawood, M. M.H. Cheung, M. Shimizu, et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1326 - 1332. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |